First, we screen all subjects before we commence immune therapy to determine if they have antibodies to SARS-CoV-2. If the results are negative, then the subject may proceed to the next step.
Second, we collect a blood donation from the subject (e.g., 400 cc).
Third, immune cells are isolated from the blood.
Fourth, the immune cells are exposed to a SARS-CoV-2 antigen.
Fifth, after a few days, the immune-antigen complex is given back to the subject via intravenous and/or lymph node injections.
Blood draws are obtained from the subject at 2 and 4 weeks.
Once the presence of IgG antibodies to SARS-CoV-2 have been documented, the subject is issued a card and a certificate verifying they are “recovered” and require no immunization for SARS-Co